Fortress Biotech (FBIO) Proxy filing summary

Executive summary

• The 2026 Annual Meeting will be held virtually on June 17, 2026, with shareholders voting on the election of seven directors and the ratification of KPMG LLP as the independent auditor for 2026.

• Shareholders of record as of April 21, 2026, are entitled to vote, with one vote per share; voting can be done online, by phone, mail, or during the meeting.

• Proxy materials are distributed electronically, with paper copies available upon request; voting instructions and technical support are provided for virtual participation.

Voting matters and shareholder proposals

• Shareholders will vote on electing seven directors for a one-year term and ratifying KPMG LLP as the independent registered public accounting firm for 2026.

• The Board recommends voting FOR all director nominees and FOR the ratification of KPMG LLP.

• Shareholders may submit proposals for the 2027 Annual Meeting by December 29, 2026, and director nominations must comply with advance notice requirements.

Board of directors and corporate governance

• The Board consists of seven members, with a mix of executive and independent directors; independence is reviewed annually per Nasdaq standards.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, each with defined charters and independent membership.

• Directors are evaluated on experience, integrity, and commitment; stockholders can recommend candidates for nomination.

• Directors are expected to attend all meetings, and a process exists for shareholder communications with the Board.